DrugPatentWatch Database Preview

Details for Patent: 8,337,888

« Back to Dashboard

Summary for Patent: 8,337,888

Title:	Pharmaceutical formulation containing gelling agent
Abstract:	Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
Inventor(s):	Wright; Curtis (Norwalk, CT), Oshlack; Benjamin (New York, NY), Breder; Christopher (Greenwich, CT)
Assignee:	Purdue Pharma L.P. (Stamford, CT)
Application Number:	13/349,449
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,337,888
Patent Claim Types: see list of patent claims	Formulation; Compound; Dosage form;

Drugs Protected by US Patent 8,337,888

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

International Family Members for US Patent 8,337,888

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2002319774
Brazil	0212019
Brazil	0212020
Canada	2455420